183 / 464
INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG
183
Programme and Exhibition Guide |
POSTERS AND ELECTRONIC POSTERS
POSTERS
> Symptomatic pelvic insufficiency fracture in women after pelvic RT- is
there a dosimetric correlate?
Z. Horne (USA), M. Dohopolsky, S. He, B. Gill, S. Beriwal
PO-0722
POSTER
Clinical track: Prostate
> Phase II study with FFF linac-based SBRT in 5 fractions for localized
prostate cancer
F. Alongi (Italy), U. Tebano, S. Fersino, A. Fiorentino, R. Mazzola,
N. Giaj-Levra, F. Ricchetti, D. Aiello, G. Sicignano, S. Naccarato,
R. Ruggieri
PO-0723
> Moderate hypofractionated radiotherapy in prostate cancer: a meta-
analysis from randomized trials
Z. Yin (China), Z. Yuan, J. You
PO-0724
> Sigmoid colon is an important organ at risk for high-grade faecal
urgency after pelvic radiotherapy
R. Jadon (UK), P. Parsons, L. Hanna, M. Evans, J. Staffurth
PO-0725
> Dose escalation with HDR brachytherapy for intermediate- and high-
risk prostate cancer
R. Chicas-Sett (Spain), F. Celada, J. Burgos, D. Farga, M. Perez-Calatayud,
S. Roldan, E. Collado, B. Ibañez, J. Perez-Calatayud, A. Tormo
PO-0726
> Acute intestinal toxicity after whole-pelvis IMRT for prostate cancer
from the patient’s perspective
B. Noris Chiorda (Italy), E. Garibaldi, B. Saracino, D. Cante, B. Avuzzi,
E. Villa, J.M. Waskiewicz, M. Gaetano, F. Munoz, G. Girelli, C. Sini,
T. Rancati, F. Badenchini, C. Bianconi, C. Fiorino, C. Cozzarini
PO-0727
> BRCA2 mutation predicts poor survival in prostate cancer: a
compelling evidence from 8,988 patients.
M. Cui (China), X.S. Gao, X. Gu, C. Peng, X. Li, M. Ma
PO-0728
> Normal tissue complication probability for late urinary toxicities after
RT for prostate cancer
F. Palorini (Italy), A. Cicchetti, T. Rancati, C. Cozzarini, B. Avuzzi,
C. Degli Esposti, P. Franco, E. Garibaldi, G. Girelli, C. Iotti, V. Vavassori,
R. Valdagni, C. Fiorino
PO-0729